WO2010148314A3 - Preparation of esomeprazole and its pharmaceutically acceptable salts - Google Patents
Preparation of esomeprazole and its pharmaceutically acceptable salts Download PDFInfo
- Publication number
- WO2010148314A3 WO2010148314A3 PCT/US2010/039187 US2010039187W WO2010148314A3 WO 2010148314 A3 WO2010148314 A3 WO 2010148314A3 US 2010039187 W US2010039187 W US 2010039187W WO 2010148314 A3 WO2010148314 A3 WO 2010148314A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- esomeprazole
- preparation
- pharmaceutically acceptable
- acceptable salts
- processes
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Processes for the preparation of esomeprazole and its pharmaceutically acceptable salts.
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1452/CHE/2009 | 2009-06-19 | ||
IN1452CH2009 | 2009-06-19 | ||
US29261710P | 2010-01-06 | 2010-01-06 | |
US61/292,617 | 2010-01-06 | ||
IN573CH2010 | 2010-03-05 | ||
IN573/CHE/2010 | 2010-03-05 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2010148314A2 WO2010148314A2 (en) | 2010-12-23 |
WO2010148314A3 true WO2010148314A3 (en) | 2011-05-26 |
Family
ID=43357070
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2010/039187 WO2010148314A2 (en) | 2009-06-19 | 2010-06-18 | Preparation of esomeprazole and its pharmaceutically acceptable salts |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2010148314A2 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102993181B (en) * | 2012-12-26 | 2014-07-23 | 山东大学 | Preparation method of esomeprazole and preparation method of esomeprazole salt |
CN104530003A (en) * | 2014-06-10 | 2015-04-22 | 广东东阳光药业有限公司 | Preparation method of salts of pyridylmethyl sulfinyl-1H-benzimidazole compounds |
CN106366070B (en) * | 2016-08-10 | 2019-06-11 | 上海万巷制药有限公司 | A kind of preparation method of high-purity esomeprazole sodium |
CN110305108B (en) * | 2019-07-10 | 2022-05-03 | 湖南协创药品开发有限公司 | Preparation method of esomeprazole magnesium |
CN111072633A (en) * | 2019-12-19 | 2020-04-28 | 山东达因海洋生物制药股份有限公司 | Preparation method of esomeprazole magnesium trihydrate |
CN113845510A (en) * | 2020-06-27 | 2021-12-28 | 鲁南制药集团股份有限公司 | Preparation method of esomeprazole |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007013743A1 (en) * | 2005-07-28 | 2007-02-01 | Hanmi Pharm. Co., Ltd. | Method of preparing esomeprazole and salts thereof |
EP1801110A1 (en) * | 2005-12-22 | 2007-06-27 | KRKA, tovarna zdravil, d.d., Novo mesto | Esomeprazole arginine salt |
EP1847538A1 (en) * | 2006-04-21 | 2007-10-24 | Dipharma Francis S.r.l. | A process for the preparation of pyridine compounds |
US20090076277A1 (en) * | 2006-10-30 | 2009-03-19 | Dipharma Francis S.R.L. | Process for the preparation of pyridine-methylsulfinyl compounds |
-
2010
- 2010-06-18 WO PCT/US2010/039187 patent/WO2010148314A2/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007013743A1 (en) * | 2005-07-28 | 2007-02-01 | Hanmi Pharm. Co., Ltd. | Method of preparing esomeprazole and salts thereof |
EP1801110A1 (en) * | 2005-12-22 | 2007-06-27 | KRKA, tovarna zdravil, d.d., Novo mesto | Esomeprazole arginine salt |
EP1847538A1 (en) * | 2006-04-21 | 2007-10-24 | Dipharma Francis S.r.l. | A process for the preparation of pyridine compounds |
US20090076277A1 (en) * | 2006-10-30 | 2009-03-19 | Dipharma Francis S.R.L. | Process for the preparation of pyridine-methylsulfinyl compounds |
Also Published As
Publication number | Publication date |
---|---|
WO2010148314A2 (en) | 2010-12-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2009084024A3 (en) | A process for the preparation of r-sit agliptin and its pharmaceutically acceptable salts thereof | |
WO2010117738A3 (en) | Solid state forms of sitagliptin salts | |
EP2629975A4 (en) | Devices, systems, and methods for the fabrication of tissue | |
IL212339A (en) | Pyrrolobenzodiazepine derivatives and processes for the preparation thereof | |
EP2424427A4 (en) | Highly reliable ingestible event markers and methods for using the same | |
EP2220093A4 (en) | Processes for the preparation of sitagliptin and pharmaceutically acceptable salts thereof | |
ZA201300100B (en) | Indolizine derivatives,process for the preparation thereof and therapeutic use thereof | |
WO2011051971A3 (en) | Solid dispersion of rifaximin | |
WO2011133504A3 (en) | Nanozymes, methods of making nanozymes, and methods of using nanozymes | |
WO2012068441A3 (en) | Intedanib salts and solid state forms thereof | |
WO2010056656A3 (en) | Preparation of crystalline palonosetron hydrochloride | |
WO2011076212A3 (en) | Processes for the manufacture of a pharmaceutically active agent | |
WO2011079193A3 (en) | Preparation of bendamustine and its salts | |
WO2011069076A3 (en) | Sustained release donepezil formulations | |
EP2398511B8 (en) | Medical device and method for making the same | |
IL212942A (en) | Rifamycin derivatives, process for their preparation, pharmaceutical compositions comprising the same and uses thereof | |
WO2010148314A3 (en) | Preparation of esomeprazole and its pharmaceutically acceptable salts | |
EP2600880A4 (en) | Soybean extracts for the treatment of hepatic disorders | |
EP2709455A4 (en) | Processes for the preparation of 5-azaspiro[2.4]heptane-6-carboxylic acid and its derivatives | |
WO2011023954A3 (en) | Polymorphic forms of manidipine | |
HU1000565D0 (en) | Process for the preparation of pharmaceutically active compound and intermediers | |
SI2331098T1 (en) | Methods for the administration of iloperidone | |
WO2010148209A3 (en) | Preparation of montelukast | |
WO2011107921A3 (en) | Modified release composition of milnacipran | |
WO2012139074A3 (en) | Migrastatins and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 10790272 Country of ref document: EP Kind code of ref document: A2 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 9496/CHENP/2011 Country of ref document: IN |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 10790272 Country of ref document: EP Kind code of ref document: A2 |